Current Trends and Future Prospects in Autoantibodies in Liver Diseases

Dear Colleagues,

We are pleased to announce the launch of a Special Issue of Journal of Clinical Medicine entitled “Current Trends and Future Prospects in Autoantibodies in Liver Diseases”. Some autoantibodies are recognized as serological hallmarks of autoimmune liver diseases, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). Other autoantibodies are present in the sera of patients with viral hepatitis, drug-induced hepatitis, liver failure, alcohol-related diseases, and even hepatocellular carcinoma (HCC). The emergence of several types of autoantibodies may predict disease activity, treatment outcomes, or prognosis in liver diseases. On the other hand, insulin resistance may be associated with the production of autoantibodies. Non-organ-specific autoantibodies including antinuclear antibody (ANA) and smooth muscle antibody (SMA) are often present in the sera of patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

This Special Issue will explore the clinical relevance of autoantibodies in liver diseases and discuss the ongoing progress in autoantibodies in relation to liver diseases. We invite the submission of comprehensive manuscripts, including original research or review articles.

Prof. Dr. Takashi Himoto
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.